I'm transfecting siRNA using siLentFect (at 0.3 uL / well), into MDA-MB-231 cells (8000 cells/well, reverse transfection in a 96 well plate), and using Alamar Blue as the proliferative assay. At the 3rd day, there is no noticeable toxicity from the siLentFect, but significant (about 55 % relative to no treatment cells) toxicity to the negative control cells (I'm using 50 nM of the negative control). Has anyone encountered this problem before? This happened with two different negative control siRNAs (siRNAs that are not meant to bind to anything) the universal negative controls from IDT DNA, and the ones from Sigma. Can somebody please explain why this is happening?

My other problem is that I am looking at my siRNA potential to kill cells. However, when I seed at 8000 cells/well, and reverse transfect, I find that the cells in the no treatment group are confluent at day 4. I am planning on transferring the exact experimental conditions (media volume, [siRNA], cell density, and transfection volume) into a 48 well plate, so that the cells in the No treatment group could expand without interference. This should allow me to monitor any 'rebound' effects from my treated cells, and should provide a more representative values in comparing my no treatment and treatment groups. Has anyone else done this, or does anyone see any potential pitfalls with using the 48 well plates?

Lastly, I feel pretty confident using siLentFect, but I would love to hear other opinions as to using any other siRNA transfection agents? Has anyone compared siLentFect vs. Lipofectamine RNAiMax?

Similar questions and discussions